Literature DB >> 21211534

Wnt signalling mediates the cross-talk between bone marrow derived pre-adipocytic and pre-osteoblastic cell populations.

Hanna Taipaleenmäki1, Basem M Abdallah, Abdullah AlDahmash, Anna-Marja Säämänen, Moustapha Kassem.   

Abstract

The mechanisms underlying the inverse relationship between osteogenic and adipogenic differentiation of bone marrow stromal cells (MSC) are not known in detail. We have previously established two cell lines from mouse bone marrow that are committed to either osteogenic (osteoblasts and chondrocytes) (mMSC(Bone)) or adipogenic (mMSC(Adipo)) lineage. To identify the molecular mechanism determining the lineage commitment, we compared the basal gene expression profile of mMSC(Bone) versus mMSC(Adipo) using Affymetrix GeneChip® MG430A 2.0 Array. Gene annotation analysis based on biological function revealed an over-representation of skeletal development genes in mMSC(Bone) while genes related to lipid metabolism and immune response were highly expressed in mMSC(Adipo). In addition, there was a significant up-regulation of canonical Wnt signalling genes in mMSC(Bone) compared to mMSC(Adipo) (p<0.006). Dual-luciferase assay and expression analysis of genes related to Wnt signalling demonstrated significant activation of Wnt signalling pathway in mMSC(Bone) compared to mMSC(Adipo). Reduced Wnt activity in mMSC(Adipo) was associated with increased expression of the Wnt inhibitor, secreted frizzled-related protein 1 (sFRP-1) at both mRNA and protein levels in mMSC(Adipo). Interestingly, conditioned medium (CM) collected from mMSC(Adipo) (mMSC-CM(Adipo)) inhibited osteoblast differentiation of mMSC, while depletion of sFRP-1 protein from mMSC-CM(Adipo) abolished its inhibitory effect on osteoblast differentiation. Furthermore, treatment of mMSC with recombinant sFRP-1 resulted in a dose-dependent inhibition of osteoblast and stimulation of adipocyte differentiation. In conclusion, cross-talk exists between different populations of MSC in the bone marrow, and Wnt signalling functions as a molecular switch that determines the balance between osteoblastogenesis and adipogenesis.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21211534     DOI: 10.1016/j.yexcr.2010.12.015

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  45 in total

1.  Automated microscopy as a quantitative method to measure differences in adipogenic differentiation in preparations of human mesenchymal stromal cells.

Authors:  Jessica L Lo Surdo; Bryan A Millis; Steven R Bauer
Journal:  Cytotherapy       Date:  2013-08-29       Impact factor: 5.414

2.  Identification of Novel EZH2 Targets Regulating Osteogenic Differentiation in Mesenchymal Stem Cells.

Authors:  Sarah Hemming; Dimitrios Cakouros; Kate Vandyke; Melissa J Davis; Andrew C W Zannettino; Stan Gronthos
Journal:  Stem Cells Dev       Date:  2016-06-07       Impact factor: 3.272

3.  The bone-preserving effects of exendin-4 in ovariectomized rats.

Authors:  Han-Xiao Sun; Nan Lu; Dong-Mei Liu; Lin Zhao; Li-Hao Sun; Hong-Yan Zhao; Jian-Min Liu; Bei Tao
Journal:  Endocrine       Date:  2015-06-25       Impact factor: 3.633

4.  Human serum is as efficient as fetal bovine serum in supporting proliferation and differentiation of human multipotent stromal (mesenchymal) stem cells in vitro and in vivo.

Authors:  Abdullah Aldahmash; Mandana Haack-Sørensen; May Al-Nbaheen; Linda Harkness; Basem M Abdallah; Moustapha Kassem
Journal:  Stem Cell Rev Rep       Date:  2011-11       Impact factor: 5.739

5.  Impaired osteoblastogenesis in a murine model of dominant osteogenesis imperfecta: a new target for osteogenesis imperfecta pharmacological therapy.

Authors:  Roberta Gioia; Cristina Panaroni; Roberta Besio; Giovanni Palladini; Giampaolo Merlini; Vincenzo Giansanti; Ivana A Scovassi; Simona Villani; Isabella Villa; Anna Villa; Paolo Vezzoni; Ruggero Tenni; Antonio Rossi; Joan C Marini; Antonella Forlino
Journal:  Stem Cells       Date:  2012-07       Impact factor: 6.277

6.  Regulatory pathways associated with bone loss and bone marrow adiposity caused by aging, chemotherapy, glucocorticoid therapy and radiotherapy.

Authors:  Kristen R Georgiou; Susanta K Hui; Cory J Xian
Journal:  Am J Stem Cells       Date:  2012-11-30

7.  Mutation analysis of WNT10B in obese children, adolescents and adults.

Authors:  Jasmijn K Van Camp; Doreen Zegers; Stijn L Verhulst; Kim Van Hoorenbeeck; Guy Massa; An Verrijken; Kristine N Desager; Luc F Van Gaal; Wim Van Hul; Sigri Beckers
Journal:  Endocrine       Date:  2012-10-27       Impact factor: 3.633

8.  Aging alters bone-fat reciprocity by shifting in vivo mesenchymal precursor cell fate towards an adipogenic lineage.

Authors:  Lakshman Singh; Tracy A Brennan; Elizabeth Russell; Jung-Hoon Kim; Qijun Chen; F Brad Johnson; Robert J Pignolo
Journal:  Bone       Date:  2016-01-19       Impact factor: 4.398

9.  Quantitative approaches to detect donor and passage differences in adipogenic potential and clonogenicity in human bone marrow-derived mesenchymal stem cells.

Authors:  Jessica Lo Surdo; Steven R Bauer
Journal:  Tissue Eng Part C Methods       Date:  2012-06-25       Impact factor: 3.056

10.  YY1 and HDAC9c transcriptionally regulate p38-mediated mesenchymal stem cell differentiation into osteoblasts.

Authors:  Ya-Huey Chen; Chiao-Chen Chung; Yu-Chia Liu; Wei-Chen Lai; Zong-Shin Lin; Tsung-Ming Chen; Long-Yuan Li; Mien-Chie Hung
Journal:  Am J Cancer Res       Date:  2018-03-01       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.